Clinical Trial Update: Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC [Phase 2]

View source ↗

Summary

A Phase II trial of docetaxel and carboplatin with radiotherapy and surgical resection for stage III non-small cell lung cancer was terminated. Results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Stanford University | Conditions: Lung Cancer, Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2013-07-04